The relationship between single nucleotide polymorphisms of the interleukin-10 gene promoter in systemic lupus erythematosus patients in Malaysia: A pilot study

International Journal of Rheumatic Diseases

Volumn 11, Issue 2, 2008, Pages 148-154

  Hee, Chee Seng ^a   Gun, Suk Chyn ^b   Naidu, Rakesh ^c   Somnath, Sushela Devi ^a   Radhakrishnan, Ammu Kutty ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b Seremban Hospital   (Malaysia)

^c MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Interleukin 10 (IL 10); Single nucleotide polymorphisms (SNP); Systemic lupus erythematosus (SLE)

Indexed keywords

ADENINE; CYTOSINE; DNA; GUANINE; INTERLEUKIN 10; THYMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; MALAYSIA; MALE; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENESIS; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; ALLELE; CHILD; DISEASE DURATION;

EID: 58049157324     PISSN: 17561841     EISSN: 14798077     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2008.00350.x     Document Type: Article

References (33)

1. Klinman DM, Steinberg AD (1987) Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 165, 1755-60.
2. Houssiau FA (1995) Cytokines in rheumatoid arthritis. Clin Rheumatol 14, 10-3.
3. Lacki JK, Samborski W, Mackiewicz SH (1997) Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins. Clin Rheumatol 16, 275-8.
4. Llorente L, Zou W, Levy Y, Richaud-Patin Y, et al. (1995) Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181, 839-44.
5. Van der Linden MW, Westendorp RGJ, Sturk A, et al. (1997) Innate high IL-10 production is associated with susceptibility for systemic lupus erythematosus. Arthritis Rheum 40, S307.
6. Tyrrell-Price J, Lydyard PM, Isenberg DA (2001) The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus. Clin Exp Immunol 124, 118-25.
7. Ishida H, Muchamuel T, Sakaguchi S, et al. (1994) Continuous administration of anti-interleukin 10 antibodies delays the onset of autoimmunity in NZB/W F1 mice. J Exp Med 179, 305-10.
8. Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A (1997) Genetic influence on cytokine production in meningococcal disease. Lancet 349, 1912-3.
9. Eskdale J, Kube D, Tesch H, Gallagher G (1997) Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 46, 120-8.
10. Bienvenu J, Doche C, Gutowski MC, Lenoble M, Lepape A, Perdrix JP (1995) Production of proinflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulated by pentoxifylline. J Cardiovascular Pharmacol 25, 2.
11. Turner DM, Williams DM, Sankaran D, et al. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24, 1-8.
12. Kube D, Platzer C, Von Knethen A, et al. (1995) Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 7, 1-7.
13. Wasylyk B, Hahn SL, Giovane A (1993) The Ets family of transcription factors. Eur J Biochem 211, 7-I8.
14. Mavrothalassitis G, Ghysdael J (2000) Proteins of the ETS family with transcriptional repressor activity. Oncogene 19, 6524-32.
15. Keijsers V, Verweij CL, Westendorp RGJ, Breedveld FC, Huizinga TWJ (1997) IL-10 polymorphisms in relation to production and rheumatoid arthritis. Arthritis Rheum 40, S179.
16. Koch W, Kastrati A, Böttiger C, Mehilli J, Von Beckerath N, Schömig A (2001) Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159, 137-44.
17. Arosio B, Trabattoni D, Galimberti L, et al. (2004) Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 25, 1009-15.
18. Mok CC, Lanchbury JS, Chan DW, Lau CS (1998) Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythemathosus. Arthritis Rheum 41, 1090-5.
19. Hee CS, Gun SC, Naidu R, Gupta E, Somnath SD, Radhakrishnan AR (2007) Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Modern Rheumatol 17, 429-35.
20. Yu L, Yang MS, Zhao J, et al. (2004) An association between polymorphisms of the interleukin-10 gene promoter and schizophrenia in the Chinese population. Schizophrenia Res 71, 179-83.
21. Albuquerque AG, Moraes M, Vanderborght PR, et al. (2004) Tumor necrosis factor and interleukin-10 gene promoter polymorphisms in Brazilian population and in Terena Indians. Transplantation Proc 36, 825-6.
22. Tan EM, Cohen AS, Fries JF, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25, 1271-7.
23. Coakley G, Mok CC, Hajeer AH, et al. (1998) Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty's syndrome. Br J Rheumatol 37, 988-91.
24. Padyukov L, Hahn-Zoric M, Lau YL, Hanson LA (2001) Different allelic frequencies of several cytokine genes in Hong Kong Chinese and Swedish Caucasians. Genes Immunity 2, 280-3.
25. Zhao JH, Curtis D, Sham PC (2000) Model-free analysis and permutation tests for allelic associations. Hum Hered 50, 133-9.
26. Park YB, Lee SK, Kim DS, et al. (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 16, 283-8.
27. Khoa PD, Sugiyama T, Yokochi T (2005) Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus. Clin Rheumatol 24, 11-3.
28. Nath SK, Harley JB, Lee YH (2005) Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: A meta-analysis. Hum Genet 118, 225-34.
29. Rood MJ, Keijsers V, van der Linden MW, et al. (1999) Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin-10 promoter haplotypes. Ann Rheum Dis 58, 85-9.
30. Lazarus M, Hajeer AH, Turner D, et al. (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheum 24, 2314-7.
31. Crawley E, Kay R, Sillibourne J, et al. (1999) Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42, 1101-8.
32. Logar D, Kveder T, Rozman B, Dobovisek J (1990) Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 49, 627-9.
33. Gibson AW, Edberg JC, Wu J, et al. (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166, 3915-22.